Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed May 15, 2018 · 10-Q · 45 days after period end · 0001654954-18-005454
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | $1.19M | $3.28M | -$5.36M | -$2.94M |
| EPS Diluted | -$0.84 | -$2.33 | -$0.19 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end
